A 0.42-nanometer breakthrough could push transistors beyond silicon

A working transistor requires an extremely thin insulating layer known as the gate dielectric. This layer sits above the semiconductor and helps control the movement of electrons. As transistors shrink, making this insulating layer thinner can improve electrical control. The difficulty is that adding such layers to atomically thin semiconductors can disturb the delicate interface between the materials. That disruption can scatter electrons and erase some of the performance gains engineers are trying to achieve.

For years, researchers have therefore faced a difficult tradeoff. They could strengthen control over the transistor gate, or they could protect the mobility of the charge carriers moving through the device. Achieving both at once has been much harder.

Researchers at National Yang Ming Chiao Tung University (NYCU), Taiwan, working with TSMC Corporate Research, Taiwan, have now demonstrated a new way to address this problem by focusing on the interface itself.

The work, published in Nature Electronics, shows that carefully controlling the atomic boundary between a semiconductor and its insulating layer can allow the dielectric to be made extremely thin while maintaining strong electrical performance. Rather than searching for a completely different semiconductor, the researchers concentrated on the narrow region where the two materials meet, an area only a few atoms thick.

Instead of changing either the semiconductor or the gate dielectric, the NYCU researchers redesigned the interface connecting them.

The team first placed an ultrathin epitaxial aluminum layer directly onto monolayer molybdenum disulfide (MoS2). They then carefully oxidized the aluminum, producing an aluminum oxide layer about 0.42 nanometers thick. After that, they added the high κ hafnium oxide gate dielectric.

Despite being only a fraction of a nanometer thick, the engineered interface performs two important jobs.

First, it creates a smooth and continuous surface that allows the hafnium oxide to grow more uniformly over the MoS2. Second, it works as an atomic buffer that limits unwanted electrical interactions between the dielectric and the semiconductor. This protection helps electrons continue moving efficiently through the transistor channel.

In this design, the interface does more than simply keep two materials apart. It becomes a functional part of the transistor and helps the materials work together more effectively.
Using the new interface design, the researchers fabricated short-channel top-gate transistors from CVD-grown monolayer MoS2. The devices had an equivalent oxide thickness of roughly one nanometer.

Testing showed low leakage current, minimal hysteresis, and maximum transconductance of 0.45 mS μm-1 in transistors with channels measuring about 100 nanometers.

More importantly, the devices demonstrated a combination that has been difficult to achieve in atomically thin transistors: very thin dielectric scaling, strong electrostatic control, and sustained carrier transport.

Because the researchers used CVD-grown monolayer MoS2 rather than mechanically exfoliated flakes, they believe the approach brings the technology closer to materials and processes that could eventually be suitable for wafer-scale manufacturing.

The findings also point to a broader change in the way semiconductor researchers think about transistor design.

For decades, much of the effort to improve transistors has centered on discovering better semiconductor materials or making devices smaller. As transistor components approach atomic dimensions, however, the interfaces separating different materials become increasingly important.

These regions may be only a few atoms thick, yet they can strongly influence how well the materials on either side work together. The new results add to growing evidence that controlling these atomic interfaces could become as important as developing new semiconductor materials themselves.

 

Image – Researchers from NYCU and TSMC show that redefining the atomic boundary between materials can address a major engineering barrier restricting the development of next-generation semiconductor devices. Courtesy of: Springer Nature.

 

For more information:

National Yang Ming Chiao Tung University
https://www.nycu.edu.tw/nycu/en/index

Norman Noble adds engineering design services for medical implants

Norman Noble, Inc., Highland Heights, Ohio, announced in February 2026 the addition of engineering design services to its medical-implant manufacturing portfolio. The new offering supports customers developing implantable devices that require advanced laser machining of nitinol, cobalt-chromium, titanium, and other high-performance alloys, and lets device makers partner with Norman Noble at the earliest stages of product development.

Through the engineering design service, Norman Noble’s team works with customers on drawing specifications, design for manufacturability, prototyping strategy, and process development with the goal of moving from concept to validated prototype faster than is typical with sequential outsourcing. The capability builds on the company’s existing offerings in laser machining, athermal Noble STEALTH laser processing, Noble SynchroFlash, and Noble DryEPolish surface finishing — all of which are already used across the cardiovascular, structural heart, neurovascular, and orthopedic implant markets.

By adding upfront design support, Norman Noble strengthens its position as a contract development and manufacturing organization (CDMO) for complex implantable devices. The expansion reflects increasing customer demand for integrated end-to-end partners that can carry a device from early concept through validated production, particularly for nitinol implants where design choices and manufacturing methods are tightly coupled.

Norman Noble, Inc. is a privately held precision contract manufacturer headquartered in Highland Heights, Ohio. The company specializes in laser machining and finishing of nitinol and other implant-grade alloys, and supports the development and manufacture of finished medical implants for global medical device customers.

Read further here

FDA approves JenaValve Trilogy transcatheter heart valve for aortic regurgitation

JenaValve Technology, Irvine, California, received U.S. Food and Drug Administration approval on March 23, 2026 for the Trilogy Heart Valve System for the treatment of symptomatic severe aortic regurgitation in patients deemed at high or greater risk for surgical aortic valve replacement. Trilogy is the first and only transcatheter heart valve approved in the United States for aortic regurgitation, addressing a long-standing unmet need in structural heart medicine.

The Trilogy device is a self-expanding, transcatheter aortic valve implant built on a low-profile nitinol frame with porcine pericardial tissue leaflets. The device’s locator architecture is designed to engage the native aortic leaflets to provide secure anchoring in regurgitant anatomy that lacks the calcified landing zone typically used for transcatheter valves indicated for aortic stenosis.

The approval is supported by the ALIGN-AR pivotal trial, which evaluated Trilogy in patients with symptomatic severe aortic regurgitation at prohibitive or high surgical risk. The trial demonstrated meaningful reductions in regurgitation severity at one year alongside acceptable safety endpoints, providing the first prospective evidence base for a dedicated AR transcatheter device in the United States.

JenaValve Technology develops transcatheter heart valve systems for the treatment of aortic regurgitation and aortic stenosis. The company is privately held and headquartered in Irvine, California.

Read further here

Gore gains FDA approval for first deep venous stent indicated for the IVC and iliofemoral veins

W. L. Gore & Associates, Newark, Delaware, announced on January 6, 2026 that the U.S. Food and Drug Administration has approved the GORE VIABAHN FORTEGRA Venous Stent for the treatment of deep venous disease in the inferior vena cava (IVC), iliac, and iliofemoral veins. The device is the first stent approved in the United States for the IVC and iliofemoral indication, and previously received FDA Breakthrough Device designation.

The FORTEGRA Venous Stent (formerly the GORE VIAFORT Vascular Stent) consists of an open-structure, self-expanding wire-wound nitinol frame and an expanded polytetrafluoroethylene (ePTFE) polymer lattice. The combination is designed to balance conformability to the natural venous anatomy with compression resistance throughout the entire device length, while the wound nitinol architecture supports fracture resistance under the dynamic mechanical loading characteristic of large-vein anatomy.

Approval was supported by an international pivotal trial that evaluated 89 patients with deep venous disease across the IVC, iliac, and iliofemoral veins. The device met its primary safety and effectiveness endpoints and demonstrated patency, freedom from clinically driven reintervention, and safety performance consistent with a first-line venous stent indication.

W. L. Gore & Associates is a privately held global manufacturing company founded in 1958 and headquartered in Newark, Delaware. Its medical products division supplies cardiovascular, vascular, structural heart, and surgical solutions in more than 50 countries and has served the deep venous disease space through prior peripheral and arteriovenous platforms.

Read further here

Wisconsin Oven ships draw batch oven to the military

Wisconsin Oven Corp., East Troy, Wisconsin, announced the shipment of an Electrically Heated Standard Draw Batch Oven (SDB Series) to a United States Military Base. The industrial oven will be used for heat treating aerospace components and features combination-style airflow delivering both horizontal and vertical upward flow for optimal heating rates and consistent temperature distribution. Temperature uniformity of ±5°F was verified at set points of 200°F, 700°F, and 1200°F in accordance with a Class 1 Temperature Uniformity Survey per AMS 2750H. The oven incorporates CAN-style construction with a heavy plate exterior and 6 inches of high-temperature industrial insulation, a 15,000 CFM recirculation system with variable frequency drive, and a UL508A-certified control panel.

Read further here

Dynalloy transfers Flexinol actuator wire technology to insulin pump leader

Dynalloy Inc., Irvine, California, announced the transfer of its Flexinol actuator wire technology, equipment, personnel, and know-how to support vertical integration at one of the world’s largest providers of insulin pump delivery products. The agreement also includes exclusivity for direct-to-human drug delivery applications.

Flexinol actuator wires are made of nickel-titanium shape memory alloy and contract when electrically heated, functioning as compact, silent, lightweight actuators ideally suited for the precise mechanisms required in miniaturized medical devices. The technology transfer enables the insulin pump manufacturer to integrate advanced SMA actuator capabilities directly into its production operations.

In response to the transfer, Dynalloy has relocated to new state-of-the-art facilities to support increased Flexinol actuator wire manufacturing and related value-added products and sub-assemblies for its broader customer base spanning automotive, consumer electronics, aerospace, and industrial automation applications.

[www.dynalloy.com](https://www.dynalloy.com)

PRIME Project Launches to Strengthen Global Nitinol Supply Chain

Five leading companies in the medical device industry have launched the PRIME project, a strategic initiative dedicated to advancing the consistency, scalability, and performance of nitinol materials. PRIME, which stands for PRoficient Ingot Material Evaluation, brings together deep technical expertise from every stage of the nitinol value chain.

The founding members are Fort Wayne Metals (ingot melting), Vascotube and Euroflex (tube drawing), and Admedes and MeKo MedTech (component manufacturing). Together, the consortium spans the complete nitinol production chain from melting through tube processing to final device assembly.

The initiative was created to strengthen supply chain stability and meet rising market demands through joint testing, real-world validation, and transparent evaluation of new ingot sources. A key goal is to prevent monopolistic dependencies and mitigate future supply risks for critical medical applications such as stents and heart valve frames.

Technical papers with testing data will be made available through the consortium’s website, and ingots, tubes, and components will be available for independent testing and production validation.

Read further here

Resonetics to Acquire Resolution Medical, Expanding Neuromodulation and Structural Heart Capabilities

Resonetics, Nashua, New Hampshire, announced that it has signed an agreement to acquire Resolution Medical, a medical device design and manufacturing firm headquartered in Fridley, Minnesota, with additional operations in the Netherlands. The transaction is expected to close in 2026, pending regulatory approvals.

The acquisition adds complementary capabilities in high-growth therapeutic markets including neuromodulation, structural heart, and interventional cardiology. Resolution Medical brings integrated design engineering, new product introduction, and cleanroom production capabilities for Class II and Class III devices, along with a team of more than 240 employees, including over 100 engineers.

“This acquisition will enhance our ability to deliver fully integrated solutions for customers in high-growth markets,” said Kevin Kelly, chief executive officer of Resonetics. The deal marks Resonetics’ third acquisition in the past 12 months as the company continues to broaden its medical device manufacturing platform.

Resonetics specializes in laser processing, nitinol components, and advanced manufacturing for the medical device industry.

Read further here

Novel AI method sharpens 3D x-ray vision

Researchers at Brookhaven National Laboratory have developed a new X-ray tomography method called the perception fused iterative tomography reconstruction engine (PFITRE), a novel approach that combines the physics of X-rays with the power of artificial intelligence (AI).

Continue reading

Stacking up: A new take on diamond electronics

Researchers at the U.S. Department of Energy’s Argonne National Laboratory have overcome a critical barrier in diamond-based electronics and microelectronics by using nanotechnology to integrate two-dimensional materials for efficient n-type doping, a breakthrough in electronic materials designed to operate in high-temperature environments and other harsh environments.

Continue reading